Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients.
Adult
Aged
Aged, 80 and over
Alzheimer Disease
/ metabolism
Amyloid beta-Protein Precursor
/ genetics
Biomarkers
/ metabolism
Cells, Cultured
Female
Humans
Induced Pluripotent Stem Cells
/ metabolism
Male
Middle Aged
Neural Stem Cells
/ metabolism
Neurons
/ metabolism
Phosphorylation
/ drug effects
Protein Kinase Inhibitors
/ pharmacology
Proto-Oncogene Proteins c-fyn
/ antagonists & inhibitors
Transfection
Tyrosine
/ metabolism
Fyn tyrosine kinase
Tyr682 residue
YENPTY domain
amyloid beta
amyloid precursor protein
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
30 07 2020
30 07 2020
Historique:
received:
22
06
2020
revised:
23
07
2020
accepted:
27
07
2020
entrez:
6
8
2020
pubmed:
6
8
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Alzheimer's disease (AD) is an incurable neurodegenerative disorder with a few early detection strategies. We previously proposed the amyloid precursor protein (APP) tyrosine 682 (Tyr682) residue as a valuable target for the development of new innovative pharmacologic or diagnostic interventions in AD. Indeed, when APP is phosphorylated at Tyr682, it is forced into acidic neuronal compartments where it is processed to generate neurotoxic amyloid β peptides. Of interest, Fyn tyrosine kinase (TK) interaction with APP Tyr682 residue increases in AD neurons. Here we proved that when Fyn TK was overexpressed it elicited APP Tyr682 phosphorylation in neurons from healthy donors and promoted the amyloidogenic APP processing with Aβ peptides accumulation and neuronal death. Phosphorylation of APP at Tyr (pAPP-Tyr) increased in neurons of AD patients and AD neurons that exhibited high pAPP-Tyr also had higher Fyn TK activity. Fyn TK inhibition abolished the pAPP-Tyr and reduced Aβ42 secretion in AD neurons. In addition, the multidomain adaptor protein Fe65 controlled the Fyn-mediated pAPP-Tyr, warranting the possibility of targeting the Fe65-APP-Fyn pathway to develop innovative strategies in AD. Altogether, these results strongly emphasize the relevance of focusing on pAPP Tyr682 either for diagnostic purposes, as an early biomarker of the disease, or for pharmacological targeting, using Fyn TKI.
Identifiants
pubmed: 32751526
pii: cells9081807
doi: 10.3390/cells9081807
pmc: PMC7463977
pii:
doi:
Substances chimiques
APP protein, human
0
Amyloid beta-Protein Precursor
0
Biomarkers
0
Protein Kinase Inhibitors
0
Tyrosine
42HK56048U
FYN protein, human
EC 2.7.10.2
Proto-Oncogene Proteins c-fyn
EC 2.7.10.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):1389-1394
pubmed: 28115709
Ageing Res Rev. 2019 Jul;52:120-128
pubmed: 31039414
Ann Neurol. 2015 Jun;77(6):953-71
pubmed: 25707991
Ann N Y Acad Sci. 2002 Nov;973:323-33
pubmed: 12485888
Int J Mol Sci. 2015 Dec 10;16(12):29446-53
pubmed: 26690411
PLoS One. 2011;6(7):e22108
pubmed: 21818298
Alzheimers Res Ther. 2015 Apr 14;7(1):35
pubmed: 25874001
J Biol Chem. 2011 Mar 18;286(11):8717-21
pubmed: 21266574
J Neurosci. 2015 Dec 9;35(49):16018-33
pubmed: 26658856
Bioessays. 2013 Oct;35(10):847-52
pubmed: 23943322
Science. 1999 Oct 22;286(5440):735-41
pubmed: 10531052
IUBMB Life. 2012 Dec;64(12):936-42
pubmed: 23129269
J Neurosci. 2005 Oct 19;25(42):9694-703
pubmed: 16237174
J Biol Chem. 2001 Jun 8;276(23):19787-92
pubmed: 11279131
Alzheimers Res Ther. 2011 Apr 19;3(2):16
pubmed: 21504563
Front Mol Neurosci. 2017 Mar 30;10:87
pubmed: 28424586
J Alzheimers Dis. 2016 Jul 14;53(4):1617-30
pubmed: 27540966
Nat Neurosci. 2012 Sep;15(9):1227-35
pubmed: 22820466
Biochim Biophys Acta. 2016 Nov;1862(11):2158-2167
pubmed: 27565738
Prog Neurobiol. 2008 Aug;85(4):393-406
pubmed: 18603345
Aging Cell. 2012 Dec;11(6):1084-93
pubmed: 23020178
J Biol Chem. 1994 Nov 25;269(47):29817-24
pubmed: 7961974
Neuroreport. 1993 Apr;4(4):435-7
pubmed: 8388744
Adv Exp Med Biol. 1998;446:161-80
pubmed: 10079843
J Biol Chem. 2001 Oct 26;276(43):40288-92
pubmed: 11544248
Biochemistry. 2010 Aug 31;49(34):7255-63
pubmed: 20687525
EMBO Mol Med. 2013 Aug;5(8):1247-62
pubmed: 23737459
J Alzheimers Dis. 2009;16(2):301-7
pubmed: 19221419
Eur J Biochem. 2001 Oct;268(20):5329-36
pubmed: 11606195
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006288
pubmed: 22355794
J Nucl Med. 2019 Dec;60(12):1780-1786
pubmed: 31101744
J Cell Biol. 2001 Oct 29;155(3):447-58
pubmed: 11684709
Neurosci Lett. 2016 Feb 2;613:54-9
pubmed: 26742640
Front Mol Neurosci. 2017 Mar 15;10:59
pubmed: 28360834
Front Cell Neurosci. 2015 Apr 07;9:109
pubmed: 25904844
Alzheimers Res Ther. 2014 Feb 05;6(1):8
pubmed: 24495408
Cell Mol Biol Lett. 2015 Mar;20(1):66-87
pubmed: 26204394
J Neurosci. 2004 May 12;24(19):4692-7
pubmed: 15140940
Exp Neurol. 2004 Feb;185(2):208-19
pubmed: 14736502
J Biol Chem. 2003 Dec 19;278(51):51100-7
pubmed: 14527950
Front Mol Neurosci. 2017 May 11;10:140
pubmed: 28553201
J Biol Chem. 2014 Apr 18;289(16):11007-19
pubmed: 24610780
J Cell Sci. 1998 Nov;111 ( Pt 21):3167-77
pubmed: 9763511
J Neurochem. 2010 Dec;115(6):1299-308
pubmed: 21039524
Acta Neuropathol. 2015 Jan;129(1):1-19
pubmed: 25287911
J Neurosci. 2002 Jan 1;22(1):10-20
pubmed: 11756483
Genes Cells. 1996 Feb;1(2):147-69
pubmed: 9140060
J Biol Chem. 1997 Dec 26;272(52):32869-77
pubmed: 9407065
Prog Neurobiol. 2017 Sep;156:189-213
pubmed: 28587768
J Biol Chem. 1993 Oct 25;268(30):22557-65
pubmed: 8226767
Neurobiol Aging. 2012 Apr;33(4):825.e15-24
pubmed: 21741124
J Neurosci. 2011 Aug 17;31(33):11756-61
pubmed: 21849536
Mol Neurodegener. 2009 Jul 14;4:28
pubmed: 19602287
Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11358-63
pubmed: 19549834
Folia Neuropathol. 2014;52(3):211-25
pubmed: 25310732
J Neurosci. 2004 Mar 3;24(9):2304-12
pubmed: 14999081
J Neurochem. 1999 Feb;72(2):576-84
pubmed: 9930729
Curr Opin Neurobiol. 2020 Apr;61:116-124
pubmed: 32197217
EMBO J. 1993 Jul;12(7):2617-24
pubmed: 7687536
J Alzheimers Dis. 2011;27(2):243-52
pubmed: 21799250
CNS Neurol Disord Drug Targets. 2018 Apr 26;17(1):14-21
pubmed: 28571531
J Biol Chem. 2001 Jan 5;276(1):693-9
pubmed: 11024032
J Neurosci Res. 2008 Mar;86(4):744-54
pubmed: 17828772
Int J Mol Sci. 2020 Jun 22;21(12):
pubmed: 32580508
Mol Cell Biol. 1994 Jul;14(7):4509-21
pubmed: 7516469
Eur J Neurosci. 2013 Jun;37(12):1925-30
pubmed: 23773061
Alzheimers Dement. 2020 Jan 3;:
pubmed: 31706733
J Biol Chem. 2004 May 21;279(21):22084-91
pubmed: 15031292
EMBO Rep. 2008 Nov;9(11):1134-40
pubmed: 18833287
Neural Plast. 2017;2017:1892612
pubmed: 28634550
J Biol Chem. 1999 Jul 2;274(27):18851-6
pubmed: 10383380
Biol Psychiatry. 2018 Feb 15;83(4):369-376
pubmed: 28709498